Furthermore, overexpression of Survivin is a prognostic biomarker for decreased patient survival in multiple cancers, e.g., breast cancer, colorectal and gastric carcinomas, neuroblastoma and NSCLC. The gene discussed is BIRC5; the disease is gastric carcinoma.